Craig A. Swandal is Director of Apyx Medical Corp. Currently has a direct ownership of 17,000 shares of APYX, which is worth approximately $24,650. The most recent transaction as insider was on Mar 21, 2022, when has been sold 17,000 shares (Common Stock) at a price of $4.98 per share, resulting in proceeds of $84,660. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17K
0% 3M change
0% 12M change
Total Value Held $24,650

Craig A. Swandal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 21 2022
BUY
Exercise of conversion of derivative security
$84,660 $4.98 p/Share
17,000 Added 50.0%
17,000 Common Stock
Jan 07 2022
BUY
Exercise of conversion of derivative security
$67,569 $9.42 p/Share
7,173 Added 10.65%
60,173 Common Stock
CAS

Craig A. Swandal

Director
Clearwater, FL

Track Institutional and Insider Activities on APYX

Follow Apyx Medical Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APYX shares.

Notify only if

Insider Trading

Get notified when an Apyx Medical Corp insider buys or sells APYX shares.

Notify only if

News

Receive news related to Apyx Medical Corp

Track Activities on APYX